Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis

Objective: Janus kinase (JAK) inhibitors are a novel class of drugs that have shown efficacy in treating immune-mediated inflammatory diseases (IMIDs). However, their safety profile in terms of herpes zoster infection remains unclear. We aimed to evaluate the risk of herpes zoster associated with JA...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qingling, He, Liyuan, Yin, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442487/
https://www.ncbi.nlm.nih.gov/pubmed/37614317
http://dx.doi.org/10.3389/fphar.2023.1241954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442487/
https://www.ncbi.nlm.nih.gov/pubmed/37614317
http://dx.doi.org/10.3389/fphar.2023.1241954

Ejemplares similares